Implant-supported Rehabilitation With SPAL Technique or Soft Tissue Augmentation
NCT05610748 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66
Last updated 2025-03-27
Summary
The primary aim of the present study is to compare the Sub-periosteal Peri-implant Augmented Layer (SPAL) technique and soft tissue augmentation (STA), performed simultaneously to implant placement, in terms of (i) implant survival rate and (ii) health/disease condition of the peri-implant tissues at 6 and 12 months following implant loading. The secondary aim of the project will be to compare the SPAL technique and STA in terms of intra- and post-operative morbidity.
The study is designed as a single-blind, parallel-arm, randomized clinical trial. Patients will be recruited and treated at the Operative Unit of Dentistry, Azienda Unità Sanitaria Locale (A.U.S.L.) of Ferrara, Italy, and one University center (Research Centre for the Study of Periodontal and Peri-implant Diseases, University of Ferrara, Italy). Each patient will contribute the study with one sextant ("experimental sextant"). Each eligible patient will be randomly assigned to receive SPAL technique or STA according to a computer-generated randomization list. Surgical procedures will be performed by experienced periodontal and implant surgeons. Two calibrated, blinded examiners will take care of the assessment of clinical and radiographic parameters, Case Report Form (CRF) filling, as well as data extraction from CRFs for the preparation of the study database.
The proportion of patients free from peri-implantitis at 12 months following loading will be the primary outcome variable of the study. The proportion of patients with complete resolution of the bone dehiscence (BD), dimensional variations and 12-months characteristics of BD, and patient-reported outcome measures will be the secondary outcomes. The design will test two hypotheses, with a non-inferiority trial in terms of primary outcome and a superiority trial in terms of secondary outcomes.
Conditions
- Dehiscence
- Alveolar Ridge Enlargement
- Bone Loss, Alveolar
Interventions
- PROCEDURE
-
Sub-Periosteal Peri-implant Augmented Layer technique
In patients assigned to the SPAL group, the management of the soft tissues will be performed according to the SPAL technique as originally described by Trombelli et al. (2018). Implant site preparation will be performed using a set of calibrated guided surgery steel burs under copious sterile saline irrigation. Implants will be placed, and a healing abutment will be positioned and screwed. The space underneath the periosteal layer will be then filled with a deproteinized bovine bone mineral (DBBM) graft. A sterile viscoelastic gel (SVG) based on polynucleotides and hyaluronic acid (REGENFAST®, Mastelli Srl, Sanremo, Italia) will be combined with the bone graft. The periosteal layer will be then secured to the oral flap by mean of 6/0 resorbable internal mattress sutures. SVG wil be placed underneath the mucosal layer and the latter will be coronally advanced and stabilized a using 6/0 resorbable internal mattress and sling sutures.
- PROCEDURE
-
Soft tissue augmentation
In patients assigned to the STA group, flap management will be performed as described by Stefanini et al. (2016). Implant site preparation will be performed according to the same procedures described for the SPAL group. SVG will be placed underneath the buccal flap and the latter will be then released from tension by means of periosteal and muscular incisions, and will be coronally advanced and adapted to the healing abutment with a 6/0 resorbable sling suture. Interrupted sutures will be used to accomplish primary intention closure in the interproximal areas.
Sponsors & Collaborators
-
Azienda USL Ferrara
collaborator OTHER_GOV -
Università degli Studi di Ferrara
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2025-07-31
- Completion
- 2025-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Peri Implant Soft Tissue Healing in Single Implant Restoration Using Two Different Techniques
NCT02513368 ·Status: COMPLETED ·Phase: PHASE2
-
Leukocyte-platelet Rich Fibrin for Alveolar Ridge Preservation
NCT05572242 ·Status: UNKNOWN ·Phase: NA
-
Comparison of The Post-Extraction Dimensional Alterations Following Ridge Preservation Using Autogenous Partially and Completely Demineralized Dentin Grafts Versus Autogenous Whole-tooth Graft
NCT05766137 ·Status: UNKNOWN ·Phase: NA
-
Freeze-dried Bone Allograft vs Autologous Bone Blocks in the Lateral Augmentation of the Jaws
NCT07104370 ·Status: RECRUITING ·Phase: NA
-
The Use of Platelet-rich Fibrin (PRF) Membranes in Lateral Alveolar Ridge Augmentation When Jaw Bone is Missing Before Dental Implant Installation. A Study Comparing an Autogenous Bone Block Graft Covered Either by a (PRF) Membrane (Test) or Bone Substitute and a Barrier Membrane (Control)
NCT04350749 ·Status: COMPLETED ·Phase: PHASE4
-
Horizontal Bone Augmentation of Alveolar Ridge
NCT06420713 ·Status: COMPLETED ·Phase: NA
-
Horizontal Ridge Augmentation With or Without Autogenous Block Grafts
NCT03432702 ·Status: COMPLETED ·Phase: NA
-
Effectiveness in Limiting the Need to Elevate the Maxillary Sinus
NCT03357705 ·Status: COMPLETED ·Phase: NA
-
The Influence of Bone Allograft Particle Sizes on the Quantity and Quality of New Bone Formation in Grafted Extraction Sockets and Edentulous Ridges
NCT03468998 ·Status: COMPLETED ·Phase: NA
-
Hyaluronic Acid and Polynucleotides in Ridge Preservation
NCT07099846 ·Status: RECRUITING ·Phase: NA
-
Effect of Symphysis Onlay Bone Graft, Injectable Platelet Rich Fibrin (I-PRF) and Xenograft on Horizontal Alveolar Ridge Augmentation in Esthetic Zone
NCT06388837 ·Status: COMPLETED ·Phase: NA
-
Reliability of All on 4 Using 2 Zygomatic and 2 Conventional Implants vs All on 4 Implants for Rehabilitation of Maxilla
NCT05108324 ·Status: UNKNOWN ·Phase: NA
-
Maxillary Sinus Augmentation With Xenogeneic Bone Graft Associated or Not With Fibrin Rich in Platelets and Leukocytes Produced by Horizontal Centrifugation: A Randomized Clinical Trial.
NCT05957705 ·Status: COMPLETED ·Phase: NA
-
Comparative Results of Six Biomaterials Used in Two-stage Maxillary Sinus
NCT03496688 ·Status: COMPLETED ·Phase: NA
-
Retrospective Observational Study of Implant-supported Restorations With Dental Implants.
NCT06154057 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effectiveness of Alveolar Bone Preservation in Alveoli With Infectious Process
NCT06661863 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Alveolar Ridge Preservation Using Different Bone Substitutes
NCT05812872 ·Status: COMPLETED ·Phase: PHASE3
-
Demineralized Whole-tooth vs Demineralized Particulate Dentin Grafts in Alveolar Ridge Preservation
NCT05336149 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Bone Behavior in Maxillary Post-extractive Sites Treated With Guided Bone Regeneration (G.B.R.) Techniques in Alveolar Socket Preservation (A.S.P.) Procedures With Different Autologous and Heterologous Biomaterials.
NCT07269990 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and PRF
NCT07079917 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Ridge Splitting With Simultaneous Implant Placement Using i-PRF
NCT05010785 ·Status: COMPLETED ·Phase: NA
-
Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2
NCT01541345 ·Status: COMPLETED ·Phase: PHASE3
-
Alveolar Ridge and Soft Tissue Augmentation Using Graft From the Maxillary Tuberosity
NCT05670067 ·Status: COMPLETED ·Phase: NA
-
10 Year Follow up of RCT Comparing Different Regenerative Regenerative Procedures
NCT05225142 ·Status: COMPLETED ·Phase: NA
-
Immediate Implant Placement With Provisionalization Using Different Bone Grafts as a Space Filling Material in the Maxillary Esthetic Zone
NCT03741036 ·Status: UNKNOWN ·Phase: NA